IP Library Patent Application 12051726
Patent Application
App. No. 12/051,726

RARE EARTH METAL COMPOSITIONS FOR TREATING HYPERPHOSPHATEMIA AND RELATED METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/051,726
Abstract

Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.

Claims (10)

1 . A method of treating hyperphosphatemia in a mammal, wherein the method comprises administering an effective amount of a composition comprising a rare earth metal compound to the mammal, and wherein the rare earth metal compound exhibits an X-Ray diffraction scan as shown in FIG. 16 , and wherein the rare earth metal compound has a phosphate binding capacity of at least 50 mg PO 4 /g of rare earth metal compound.

2 . The method according to claim 1 , wherein the rare earth metal compound comprises particles, and wherein the particles are between 1 and 1000 μm in size.

3 . The method according to claim 1 , wherein the rare earth metal compound has a phosphate binding capacity of at least 75 mg PO 4 /g of rare earth metal compound.

4 . The method according to claim 1 , wherein the rare earth metal compound has a BET specific surface area of at least about 10 m 2 /g.

5 . The method according to claim 1 , wherein the rare earth metal compound is hydrated.

6 . The method according to claim 2 , wherein the particles comprise individual crystals.

7 . The method according to claim 6 , wherein the rare earth metal compound has a phosphate binding capacity of at least 75 mg PO 4 /g of rare earth metal compound.

8 . The method according to claim 7 , wherein the rare earth metal compound has a BET specific surface area of at least about 10 m 2 /g.

9 . The method according to claim 8 , wherein the rare earth metal compound has a phosphate binding capacity of at least 100 mg PO 4 /g of rare earth metal compound.

10 . The method according to claim 8 , wherein the individual crystals are between 20 nm and 10 μm in size.

Assignments (3)
CORRECTIVE ASSIGNEMENT TO CORRECT SPELLING OF ASSGNEE'S NAME PROVIOUSLY RECORDED ON REEL 024910 FRAME 0439 Recorded Sep 28, 2010
From: ALTAIRNANO, INC.
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 025057/0430 →
CORRECTION TO REEL FRAME 023463/0076 - CORRECTION TO ASSIGNEE'S NAME AND CORRECTION TO LANGUGAGE CONTAINED IN THE BODY OF THE ASSIGNMENT DOCUMENT. Recorded Aug 25, 2010
From: ALTAIRNANO, INC.
To: SPECTRUM PHARMACEUTALS, INC.
Reel/Frame 024910/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2009
From: ALTAIR NANOMATERIALS, INC.
To: SPECTRUM PHARAMACEUTICALS, INC.
Reel/Frame 023463/0676 →